Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts

Laryngoscope

Volumn 110, Issue 1, 2000, Pages 126-131

  Miyanohara, Toshio ^b   Ushikai, Masato ^b   Matsune, Shoji ^b   Ueno, Kazuyoshi ^b   Katahira, Shoko ^b   Kurono, Yuichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NONE

Author keywords

Clarithromycin; Fibroblast; Intercellular adhesion molecule 1; Interleukin 1 ; Nasal epithelial cell; NF B

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; DEXAMETHASONE; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MACROLIDE; MESSENGER RNA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CHRONIC SINUSITIS; DNA BINDING; DRUG EFFECT; FIBROBLAST CULTURE; GENE EXPRESSION; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; NOSE MUCOSA; PRIORITY JOURNAL; SINUSITIS;

EID: 0033984382     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200001000-00023     Document Type: Article

References (39)

1. Kikuchi S, Suzaki H, Nomura Y. Clinical effect of long-term low-dose erythromycin therapy for chronic sinusitis [in Japanese with English abstract]. Pract Otol (Kyoto) 1991; 81:41-47.
2. Hashima M, Baba S. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol (Stockh) 1996(Suppl 525):73-78.
3. Kadota J, Saito O, Hara K, et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993;147:153-159.
4. Nagai H, Shishido M, Kurashima A, et al. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 1991;58:145-149.
5. Shirai T, Sato A, Chida T. Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity. Intern Med 1995;34: 469-474.
6. Fujii T, Kadota J, Kohno S, et al. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax 1995;50:1246-1252.
7. Khair OA, Devalia JL, Davies RJ, et al. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. Eur Respir J 1995;8:1451-1457.
8. Matsuoka N, Eguchi K, Nagataki S, et al. Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells. Clin Exp Immunol 1996;104:501-508.
9. Suzuki H, Shimomura A, Takasaka T, et al. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope 1997;107: 1661-1666.
10. Oishi K, Sonoda F, Matsumoto K, et al. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect Immun 1994;62:4145-4152.
11. Morikawa K, Watabe H, Morikawa S, et al. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob Agents Chemother 1996;40: 1366-1370.
12. Morikawa K, Oseko F, Iwamoto K, et al. Immunomodulatory effects of three macrolides, midecamycin acetate, Josamycin, and clarithromycin, on human T-lymphocyte function in vitro. Am Soc Microbiol 1994;38:2643-2647.
13. Iino Y, Toriyama M, You A, et al. Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor α production by human monocytes in vitro. Ann Otol Rhinol Laryngol 1992;101:16-20.
14. Tokushige E, Itoh K, Fukuda K, et al. Localization of IL-1β mRNA and cell adhesion molecules in the maxillary sinus mucosa of patients with chronic sinusitis. Laryngoscope 1994;104:1245-1250.
15. Itoh K, Katahira S, Fukuda K, et al. Retention fluids of chronic sinusitis induce neutrophil adherence to microvascular endothelial cells. Acta Otolaryngol (Stockh) 1992;112: 882-889.
16. Papavassiliou AG. Molecular medicine transcription factors. N Engl J Med 1995;332:45-47.
17. Baeuerle PA, et al. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141
18. Barnes PJ, Karin M. Nuclear factor-κB, a pivotal transcriptional factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
19. Kopp E, Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994;265:956-959.
20. Piperno AG, Nolan P, Steinman RM, et al. The effect of immunosuppressive agents on the induction of nuclear factors that blind to sites on the interleukin 2 promoter. J Exp Med 1990;172:1869-1872.
21. Suwa T, Urano H, Watanabe H, et al. Pharmacokinetic study of TE-031 (8). Absorption and excretion following oral administration of healthy volunteers [in Japanese]. Chemotherapy (Tokyo) 1988;36:75-85.
22. Westphal O, Jann K. Bacterial lipopolysaccharide. In: Whistler RL, ed. Methods in Carbohydrate Chemistry. San Diego: Academic;1965;5:83-91.
23. Hanamure Y, Deguchi K, Ohyama M. Ciliogenesis and mucus synthesis in cultured human respiratory epithelial cells. Ann Otol Rhinol Laryngol 1994;103:889-895.
24. Matsuzaki T, Itoh K, Fukuda K, et al. Latent collagenase production by cells derived from nasal polyps in culture. Am J Rhinol 1994;8:241-246.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thinocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
26. Schreiber E, Matthias P, Schaffner W, et al. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res 1989;17: 6419.
27. Manthous CA, Hall JB, Samsel RW. Endotoxin in human disease. Chest 1993;104:1872-1881.
28. Frank O, Evans JR, Gwaleney JR. Sinusitis of the maxillary antrum. N Engl J Med 1975;293:735-739.
29. Denny FW. Effect of a toxin produced by Haemophilus influenzae on ciliated respiratory epithelium. J Infect Dis 1974; 129:93-100.
30. Khair OA, Davies RJ, Devalia JL. Bacterial-induced release of inflammatory mediators by bronchial epithelial cells. Eur Respir J 1996;9:1913-1922.
31. Mukaida N, Ishikawa Y, Matsushima K. Novel insight into molecular mechanism of endotoxin shock: biochemical analysis of LPS receptor signaling in a cell-free system targeting NF-κB and regulation of cytokine production/action through β2 integrin in vivo. J Leukoc Biol 1996;59: 145-51.
32. Clark BD, Collins KL, Auron PE. Genomic sequence for human prointerleukin 1 β: possible evolution from a reverse transcribed prointerleukin-1α gene. Nucleic Acids Res 1986;14:7897-7914.
33. Xing Z, Jordana M, Grauldie J, et al. Lipopolysaccharide induces expression of granulocyte/macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts: evidence for heterogeneity within the respiratory tract. Am J Respir Cell Mol Biol 1993;9:255-263.
34. Kaneko M, Inoue H, Saito I, et al. Pirfenidone induces intercellular adhesion molecular-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts. Clin Exp Immunol 1998;113:72-76.
35. Xu SW, Denton CP, Black CM, et al. Endothelin-1 regulation of intercellular adhesion molecule-1 expression in normal and sclerodermal fibroblasts. J Cardiovasc Pharmacol 1998;31:545-547.
36. Murakami S, Okada H. Lymphocyte-fibroblast interactions. Crit Rev Oral Biol Med 1997;8:40-50.
37. Paulsung KL, Kuhlman P, Brian AA, et al. Force contribution of the LFA-1/ICAM-1 complex to T cell adhesion. J Cell Science 1992;103:259-266.
38. Shang XZ, Issekutz AC. Contribution of CD11a/CD18, CD11b/CD18, ICAM-1 (CD54) and -2 (CD102) to human monocyte migration through endothelium and connective tissue fibroblasts barriers. Eur J Immunol 1998;28: 1970-1979.
39. Voraberger G, Schaefer R, Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region. J Immunol 1991;147:2777-2786.